What is Citius Oncology, Inc.'s operating cash flow?

Citius Oncology, Inc. (CTOR) reported operating cash flow of -$3.83M in Q1 2026.

How has Citius Oncology, Inc.'s operating cash flow changed year-over-year?

Citius Oncology, Inc.'s operating cash flow decreased by 179.1% year-over-year, from -$1.37M to -$3.83M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Citius Oncology, Inc. CTOR Operating Cash Flow

Operating Cash Flow at other companies

Merck & Co.MRK

$3.92B+56.7%

Delcath SystemsDCTH

$857K-61.1%

Iovance Biotherapeutics, Inc.IOVA

-$72.07M+30.5%

Cullinan Therapeutics, Inc.CGEM

-$46.05M-6.7%

ImmunomeIMNM

-$58.64M-10.5%

Arcus BiosciencesRCUS

-$138M-4.5%

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s operating cash flow?: Citius Oncology, Inc. (CTOR) reported operating cash flow of -$3.83M in Q1 2026.
How has Citius Oncology, Inc.'s operating cash flow changed year-over-year?: Citius Oncology, Inc.'s operating cash flow decreased by 179.1% year-over-year, from -$1.37M to -$3.83M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.